The pharmaceutical industry operates in the production of medicines, thus ensuring the health of the population. Given the importance of this industrial sector, biosafety practices become fundamental.
This is because the manufacture of drugs involves risks for workers, users and the community in general.
Want to better understand how biosafety practices work in the pharmaceutical industry ? This text will address the topic in a simple and comprehensive way. Keep reading.
You will find
What is biosecurity?
The main objective of biosafety is to ensure that scientific procedures are safe. It seeks strategies to control, reduce, or even eliminate the risks involved in activities related to science and health.
Different sectors of society, such as laboratories, hospitals, research centers, and others, must adopt biosafety practices . This means that these spaces must ensure that their activities do not pose risks to people, animals, and the environment.
Risk rating
To further the discussion on biosecurity, it is necessary to understand risk classification . There are four levels for classifying microorganisms according to the greater or lesser risk they pose.
In summary, these four levels of biosecurity are organized as follows:
- Risk 1 – microorganisms that offer very low or non-existent individual or community risk;
- risk 2 – microorganisms that offer low risk in the community, but moderate individually;
- risk 3 – microorganisms that offer limited community risk, but high individually;
- Risk 4 – microorganisms that offer high individual or community risk.
The Importance of Biosafety in the Pharmaceutical Industry
Understanding what biosecurity is makes its connection to the pharmaceutical industry evident. Inadequate practices can result in environmental contamination, the spread of diseases, infections among workers, and other potential harm.
Therefore, biosafety processes in the pharmaceutical industry require careful handling of chemicals, rigorous production control, and environmental cleaning procedures.
Cleaning, sanitization and disinfection: good practices
Good biosafety practices in the pharmaceutical industry can be categorized into three areas: cleaning, sanitizing, and disinfecting. Although they may seem similar, each has its own characteristics.
Cleaning in the pharmaceutical industry consists of the efficient removal of dirt present on the surfaces of the spaces. Its objective is the periodic removal of microorganisms present in these spaces.
Sanitization follows health surveillance guidelines, using specific products to remove agents harmful to health.
Disinfection also uses specific products, known as disinfectants, to eliminate viruses and bacteria by up to 99%.
About Asmotec
To ensure an environment conducive to biosafety practices, it is essential to have experts in the field. In this context, Asmontec is a leading partner in promoting biosafety in the pharmaceutical industry and other sectors.
With over 27 years of experience, we are the first and only cleanroom engineering company with ISO9001 certification. A benchmark in the cleanroom market, we demonstrate a commitment to safety and health in critical environments.
In a market where negligence is a growing problem, Asmontec stands out as a leader committed to ensuring safety and health, demonstrating that biosafety is an essential value in the pharmaceutical industry.
